Burstyn, U. (2010). Management of mastitis and abscessation of mammary glands secondary to fibroadenomatous hyperplasia in a primiparturient cat. Journal of the American Veterinary Medical Association, 236(3), 326-329.
Giménez, F., Hecht, S., Craig, L. E., & Legendre, A. M. (2010). Early detection, aggressive therapy: optimizing the management of feline mammary masses. Journal of Feline Medicine and Surgery, 12(3), 214-224.
Hayden, D. W., Johnston, S. D., Kiang, D. T., Johnson, K. H., & Barnes, D. M. (1981). Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects. American Journal of Veterinary Research, 42(10), 1699.
Hayes, A. A., & Mooney, S. (1985). Feline mammary tumors. Veterinary Clinics of North America: Small Animal Practice, 15(3), 513-520.
Leidinger, E., Hooijberg, E., Sick, K., Reinelt, B., & Kirtz, G. (2011). Fibroepithelial hyperplasia in an entire male cat: cytologic and histopathological features. Tierarztl Prax Ausg K Kleintiere Heimtiere, 39(3), 198-202.
MacDougall, L. D. (2003). Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate. The Canadian Veterinary Journal, 44(3), 227.
Millanta, F. A., Calandrella, M., Bari, G., Niccolini, M., Vannozzi, I, & Poli, A. L. E. S. S. A. N. D. R. O. (2005). Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in Veterinary Science, 79(3), 225-232.
Payan-Carreira, R. (2013). Feline mammary fibroepithelial hyperplasia: a clinical approach. Insights from Veterinary Medicine. InTechOpen, 215-232.
Pereira, P. D., Carvalheira, J., & Gärtner, F. (2004). Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue–an immunohistochemical study. The Veterinary Journal, 168(2), 180-185.
Wehrend, A., Hospes, R., & Gruber, A. D. (2001). Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist, 148(11), 346-7.
)